BioLife Solutions (BLFS) Competitors $23.95 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$23.96 +0.02 (+0.06%) As of 05/22/2026 05:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BLFS vs. IRTC, LIVN, NVST, LQDA, and WRBYShould you buy BioLife Solutions stock or one of its competitors? MarketBeat compares BioLife Solutions with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with BioLife Solutions include iRhythm Technologies (IRTC), LivaNova (LIVN), Envista (NVST), Liquidia (LQDA), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry. BLFS vs. IRTCBLFS vs. LIVNBLFS vs. NVSTBLFS vs. LQDABLFS vs. WRBYHow does BioLife Solutions compare to iRhythm Technologies?iRhythm Technologies (NASDAQ:IRTC) and BioLife Solutions (NASDAQ:BLFS) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment. Which has more volatility & risk, IRTC or BLFS? iRhythm Technologies has a beta of 1.33, meaning that its share price is 33% more volatile than the broader market. Comparatively, BioLife Solutions has a beta of 1.97, meaning that its share price is 97% more volatile than the broader market. Is IRTC or BLFS more profitable? BioLife Solutions has a net margin of -2.80% compared to iRhythm Technologies' net margin of -3.53%. BioLife Solutions' return on equity of 1.81% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets iRhythm Technologies-3.53% -10.26% -1.39% BioLife Solutions -2.80%1.81%1.65% Do insiders and institutionals have more ownership in IRTC or BLFS? 93.2% of BioLife Solutions shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by insiders. Comparatively, 2.2% of BioLife Solutions shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has better earnings and valuation, IRTC or BLFS? BioLife Solutions has lower revenue, but higher earnings than iRhythm Technologies. BioLife Solutions is trading at a lower price-to-earnings ratio than iRhythm Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiRhythm Technologies$747.14M5.13-$44.55M-$0.86N/ABioLife Solutions$96.21M12.16-$4.59M-$0.08N/A Does the media prefer IRTC or BLFS? In the previous week, BioLife Solutions had 6 more articles in the media than iRhythm Technologies. MarketBeat recorded 8 mentions for BioLife Solutions and 2 mentions for iRhythm Technologies. BioLife Solutions' average media sentiment score of 0.06 beat iRhythm Technologies' score of -0.08 indicating that BioLife Solutions is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral BioLife Solutions 2 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer IRTC or BLFS? iRhythm Technologies currently has a consensus price target of $191.85, suggesting a potential upside of 64.59%. BioLife Solutions has a consensus price target of $32.00, suggesting a potential upside of 33.61%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, equities analysts plainly believe iRhythm Technologies is more favorable than BioLife Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iRhythm Technologies 1 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 2 Strong Buy rating(s) 2.93BioLife Solutions 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 SummaryBioLife Solutions beats iRhythm Technologies on 11 of the 17 factors compared between the two stocks.How does BioLife Solutions compare to LivaNova?BioLife Solutions (NASDAQ:BLFS) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk. Does the media favor BLFS or LIVN? In the previous week, BioLife Solutions had 5 more articles in the media than LivaNova. MarketBeat recorded 8 mentions for BioLife Solutions and 3 mentions for LivaNova. LivaNova's average media sentiment score of 0.45 beat BioLife Solutions' score of 0.06 indicating that LivaNova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLife Solutions 2 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral LivaNova 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, BLFS or LIVN? BioLife Solutions has a beta of 1.97, meaning that its share price is 97% more volatile than the broader market. Comparatively, LivaNova has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market. Is BLFS or LIVN more profitable? LivaNova has a net margin of 7.48% compared to BioLife Solutions' net margin of -2.80%. LivaNova's return on equity of 16.48% beat BioLife Solutions' return on equity.Company Net Margins Return on Equity Return on Assets BioLife Solutions-2.80% 1.81% 1.65% LivaNova 7.48%16.48%7.59% Do analysts recommend BLFS or LIVN? BioLife Solutions presently has a consensus target price of $32.00, suggesting a potential upside of 33.61%. LivaNova has a consensus target price of $79.38, suggesting a potential upside of 7.51%. Given BioLife Solutions' higher possible upside, research analysts clearly believe BioLife Solutions is more favorable than LivaNova.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLife Solutions 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40LivaNova 0 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.67 Do institutionals & insiders hold more shares of BLFS or LIVN? 93.2% of BioLife Solutions shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 2.2% of BioLife Solutions shares are owned by company insiders. Comparatively, 0.4% of LivaNova shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has preferable earnings and valuation, BLFS or LIVN? BioLife Solutions has higher earnings, but lower revenue than LivaNova. BioLife Solutions is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioLife Solutions$96.21M12.16-$4.59M-$0.08N/ALivaNova$1.39B2.92-$242.47M$1.9537.86 SummaryLivaNova beats BioLife Solutions on 10 of the 16 factors compared between the two stocks.How does BioLife Solutions compare to Envista?BioLife Solutions (NASDAQ:BLFS) and Envista (NYSE:NVST) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability. Which has more volatility and risk, BLFS or NVST? BioLife Solutions has a beta of 1.97, suggesting that its share price is 97% more volatile than the broader market. Comparatively, Envista has a beta of 0.92, suggesting that its share price is 8% less volatile than the broader market. Which has stronger valuation & earnings, BLFS or NVST? Envista has higher revenue and earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioLife Solutions$96.21M12.16-$4.59M-$0.08N/AEnvista$2.72B1.40$47M$0.4157.09 Do insiders & institutionals hold more shares of BLFS or NVST? 93.2% of BioLife Solutions shares are held by institutional investors. 2.2% of BioLife Solutions shares are held by company insiders. Comparatively, 1.0% of Envista shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media refer more to BLFS or NVST? In the previous week, BioLife Solutions had 4 more articles in the media than Envista. MarketBeat recorded 8 mentions for BioLife Solutions and 4 mentions for Envista. Envista's average media sentiment score of 0.87 beat BioLife Solutions' score of 0.06 indicating that Envista is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLife Solutions 2 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Envista 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer BLFS or NVST? BioLife Solutions presently has a consensus price target of $32.00, indicating a potential upside of 33.61%. Envista has a consensus price target of $28.83, indicating a potential upside of 23.19%. Given BioLife Solutions' higher probable upside, analysts clearly believe BioLife Solutions is more favorable than Envista.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLife Solutions 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40Envista 0 Sell rating(s) 9 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.40 Is BLFS or NVST more profitable? Envista has a net margin of 2.41% compared to BioLife Solutions' net margin of -2.80%. Envista's return on equity of 7.11% beat BioLife Solutions' return on equity.Company Net Margins Return on Equity Return on Assets BioLife Solutions-2.80% 1.81% 1.65% Envista 2.41%7.11%3.91% SummaryEnvista beats BioLife Solutions on 9 of the 15 factors compared between the two stocks.How does BioLife Solutions compare to Liquidia?BioLife Solutions (NASDAQ:BLFS) and Liquidia (NASDAQ:LQDA) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations. Is BLFS or LQDA more profitable? Liquidia has a net margin of 7.74% compared to BioLife Solutions' net margin of -2.80%. Liquidia's return on equity of 46.82% beat BioLife Solutions' return on equity.Company Net Margins Return on Equity Return on Assets BioLife Solutions-2.80% 1.81% 1.65% Liquidia 7.74%46.82%7.06% Do analysts recommend BLFS or LQDA? BioLife Solutions currently has a consensus target price of $32.00, indicating a potential upside of 33.61%. Liquidia has a consensus target price of $49.33, indicating a potential downside of 19.10%. Given BioLife Solutions' higher possible upside, analysts plainly believe BioLife Solutions is more favorable than Liquidia.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLife Solutions 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40Liquidia 2 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 3 Strong Buy rating(s) 2.92 Do institutionals and insiders believe in BLFS or LQDA? 93.2% of BioLife Solutions shares are owned by institutional investors. Comparatively, 64.5% of Liquidia shares are owned by institutional investors. 2.2% of BioLife Solutions shares are owned by company insiders. Comparatively, 25.6% of Liquidia shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more risk and volatility, BLFS or LQDA? BioLife Solutions has a beta of 1.97, meaning that its stock price is 97% more volatile than the broader market. Comparatively, Liquidia has a beta of 0.41, meaning that its stock price is 59% less volatile than the broader market. Which has stronger earnings and valuation, BLFS or LQDA? BioLife Solutions has higher earnings, but lower revenue than Liquidia. BioLife Solutions is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioLife Solutions$96.21M12.16-$4.59M-$0.08N/ALiquidia$158.32M34.25-$68.92M$0.14435.57 Does the media favor BLFS or LQDA? In the previous week, BioLife Solutions had 2 more articles in the media than Liquidia. MarketBeat recorded 8 mentions for BioLife Solutions and 6 mentions for Liquidia. Liquidia's average media sentiment score of 0.90 beat BioLife Solutions' score of 0.06 indicating that Liquidia is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLife Solutions 2 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Liquidia 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryLiquidia beats BioLife Solutions on 12 of the 17 factors compared between the two stocks.How does BioLife Solutions compare to Warby Parker?Warby Parker (NYSE:WRBY) and BioLife Solutions (NASDAQ:BLFS) are both medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation and earnings. Do analysts prefer WRBY or BLFS? Warby Parker currently has a consensus price target of $29.50, suggesting a potential upside of 17.53%. BioLife Solutions has a consensus price target of $32.00, suggesting a potential upside of 33.61%. Given BioLife Solutions' higher probable upside, analysts clearly believe BioLife Solutions is more favorable than Warby Parker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Warby Parker 0 Sell rating(s) 5 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.64BioLife Solutions 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Does the media refer more to WRBY or BLFS? In the previous week, Warby Parker had 5 more articles in the media than BioLife Solutions. MarketBeat recorded 13 mentions for Warby Parker and 8 mentions for BioLife Solutions. Warby Parker's average media sentiment score of 0.79 beat BioLife Solutions' score of 0.06 indicating that Warby Parker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Warby Parker 8 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive BioLife Solutions 2 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher valuation & earnings, WRBY or BLFS? Warby Parker has higher revenue and earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWarby Parker$871.91M3.08$1.64M$0.021,255.00BioLife Solutions$96.21M12.16-$4.59M-$0.08N/A Is WRBY or BLFS more profitable? Warby Parker has a net margin of 0.15% compared to BioLife Solutions' net margin of -2.80%. Warby Parker's return on equity of 2.30% beat BioLife Solutions' return on equity.Company Net Margins Return on Equity Return on Assets Warby Parker0.15% 2.30% 1.18% BioLife Solutions -2.80%1.81%1.65% Do institutionals & insiders have more ownership in WRBY or BLFS? 93.2% of Warby Parker shares are owned by institutional investors. Comparatively, 93.2% of BioLife Solutions shares are owned by institutional investors. 16.8% of Warby Parker shares are owned by company insiders. Comparatively, 2.2% of BioLife Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more volatility & risk, WRBY or BLFS? Warby Parker has a beta of 1.95, suggesting that its stock price is 95% more volatile than the broader market. Comparatively, BioLife Solutions has a beta of 1.97, suggesting that its stock price is 97% more volatile than the broader market. SummaryWarby Parker beats BioLife Solutions on 11 of the 15 factors compared between the two stocks. Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLFS vs. The Competition ExportMetricBioLife SolutionsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.17B$8.52B$6.45B$12.34BDividend YieldN/A2.50%2.76%5.28%P/E Ratio-299.3416.2421.2225.65Price / Sales12.168.28553.9286.28Price / Cash104.5917.1143.4956.67Price / Book3.144.0610.377.14Net Income-$4.59M$224.05M$3.57B$335.98M7 Day Performance7.40%4.68%6.01%3.56%1 Month Performance12.02%-0.08%3.52%2.54%1 Year Performance9.96%0.98%34.13%35.05% BioLife Solutions Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLFSBioLife Solutions2.949 of 5 stars$23.95flat$32.00+33.6%+10.0%$1.17B$96.21MN/A440Gap UpHigh Trading VolumeIRTCiRhythm Technologies4.1069 of 5 stars$116.84-3.2%$193.38+65.5%-18.3%$3.97B$747.14MN/A2,400LIVNLivaNova2.1969 of 5 stars$70.09-2.5%$77.22+10.2%+76.3%$3.95B$1.39B35.943,300NVSTEnvista4.0185 of 5 stars$24.15-0.4%$28.83+19.4%+39.9%$3.94B$2.72B58.9112,000LQDALiquidia3.2521 of 5 stars$53.13+25.6%$46.78-12.0%+297.3%$3.76B$158.32MN/A50High Trading Volume Related Companies and Tools Related Companies iRhythm Technologies Competitors LivaNova Competitors Envista Competitors Liquidia Competitors Warby Parker Competitors MiniMed Group Competitors Soleno Therapeutics Competitors LeMaitre Vascular Competitors TransMedics Group Competitors AxoGen Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLFS) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
